Tissue Sectioning Instrument Market Overview

The global Tissue Sectioning Instrument market is expected to witness significant growth in the forecast period. The growing incidence of chronic diseases and cancers is the main factor for driving the demand for histopathology tests, as a tissue pathology examination is of extreme importance for the diagnosis of a malignant tumor.  Cancer is considered one of the leading causes of death worldwide.  In addition to this, biopsy tissue analysis allows pathologists to determine the type, stage, and degree of cancer in which the disease has invaded healthy tissues. This fact increased the adoption of tissue sectioning, staining instruments, and histopathology. It ultimately boosting the growth of the global Tissue Sectioning Instrument market.

Furthermore, personalized medicine is becoming the hallmark of cancer treatment and with its application expanding to other fields. Increased adoption of personalized medicine has led to an increase in demand for the use of human tissue, as the field relies on the use of human tissue for the development of innovative tests. This key fact further propelling the growth of the market.

The increasing awareness programs are undertaken by organizations, such as National Cervical Cancer Coalition, World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the U.S. Preventive Services Task Force (USPSTF), for cancer screening. This prime factor is anticipated to escalate the growth of the Tissue Sectioning Instrument market in the forthcoming years.

Covid-19 Impact on Tissue Sectioning Instrument Market:

In addition, the current Tissue Sectioning Instrument Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Tissue Sectioning Instrument Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Tissue Sectioning Instrument Market Segment Overview

Based on the product, the instruments segment accounted for the largest share of the tissue sectioning market. Microtomes and Cryostats are required for cutting uniform sections of tissues under study. Advanced versions of microtomes can precisely cut tissue blocks of thickness ranging from 0.1 to 100 μm. In addition, these devices are available in different forms, such as sliding, rotating, freezing, ultra, and laser microtomes. Hence, the availability of a broad range of products to serve different purposes in pathology labs is projected to boost the growth of the segment.

Furthermore, key market participants are mainly focusing on enhancing the reproducibility and working efficiency of Microtomes and Cryostats. The presence of various service providers involved in the sectioning of paraffin-embedded tissue, which enables cutting and mounting of very thin sections for microscopic analysis. This fact is projected to boost the growth of the segment further.

Tissue Sectioning Instrument Market, By Product

• Instruments
  • Rotary Microtome
  • Sliding Microtome
  • Ultramicrotome
  • Cryostat
  • Others
• Accessories & Consumables
• Services

Tissue Sectioning Instrument Market, By Technology

·       Automatic
·       Semiautomatic
·       Manual

Tissue Sectioning Instrument Market, By Application

·       Diagnosis
·       Research

Tissue Sectioning Instrument Market, By End-User

·       Hospitals
·       Clinics
·       Diagnostic Laboratories
·       Research Centers

Tissue Sectioning Instrument Market Regional Overview

Region-wise, North America accounted for a major share of the global Tissue Sectioning Instrument market. This can be attributed to the well-established healthcare infrastructure, increased investment in tissue diagnostics by public and private sectors as well as high adoption of fully automated technologically advanced products in this region. Likewise, the market in Asia-Pacific is expected to witness significant growth during the forecast period. Factors such as increasing clinical needs and growing R&D activities for advanced diagnostic techniques are expected to fuel the growth of the market in this region. In addition, rising healthcare expenditure and developing healthcare infrastructure are likely to create several growth opportunities for the market in this region.

Tissue Sectioning Instrument Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Tissue Sectioning Instrument Market, Key Players

·       AGD Biomedicals (P) Ltd.
·       Abcam
·       Amos Scientific Pty Ltd
·       Boeckeler Instruments, Inc.
·       Covance Inc.
·       Danaher Corporation
·       LLS ROWIAK LaserLabSolutions GmbH
·       MEDITE GmbH
·       Sakura Finetek Japan, Co., Ltd.
·       SLEE medical GmbH
·       SM Scientific Instruments Pvt. Ltd.
·       Thermo Fisher Scientific Inc.